Khouja, M., Schilhabel, A., Kotrova, M., Brüggemann, M., Kuffer, C., Blair, D., . . . Pott, C. (2021). Disease Kinetics Measured By Circulating Tumor DNA Correlates with Treatment Response after Tafasitamab in Combination with R-CHOP with or without Lenalidomide in First Line Treatment of DLBCL. Blood, 138(Supplement 1), 3498. https://doi.org/10.1182/blood-2021-153176

Khouja, Mouhamad, Anke Schilhabel, Michaela Kotrova, Monika Brüggemann, Christian Kuffer, Derek Blair, Nikos Darzentas, and Christiane Pott. "Disease Kinetics Measured By Circulating Tumor DNA Correlates with Treatment Response After Tafasitamab in Combination with R-CHOP with or Without Lenalidomide in First Line Treatment of DLBCL." Blood 138, no. Supplement 1 (2021): 3498. https://doi.org/10.1182/blood-2021-153176.

Khouja, Mouhamad, et al. "Disease Kinetics Measured By Circulating Tumor DNA Correlates with Treatment Response After Tafasitamab in Combination with R-CHOP with or Without Lenalidomide in First Line Treatment of DLBCL." Blood, vol. 138, no. Supplement 1, 2021, p. 3498, https://doi.org/10.1182/blood-2021-153176.